Stocks
Health Care
alny
Alnylam Pharmaceuticals
NASDAQ: ALNY
+27.38 (+6.02%)
482.41
USD
At close at Sep 09, 20:38 UTC
Income Statement
Revenue
2.25B
Gross Profit
1.92B
Operating Income
-176.88M
Pretax Income
-379.57M
Net Income
-278.16M
EBITDA
-200.50M
EBIT
-235.52M
Earnings Per Share
-2.17
Balance Sheet
Cash & Cash Equivalents
929.18M
Total Debt
2.81B
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
-30.72M
Book Value Per Share
-0.24
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.